HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas

被引:28
作者
Jaeger, Daniela [1 ]
Barth, Thomas F. E. [1 ]
Bruederlein, Silke [1 ]
Scheuerle, Angelika [1 ]
Rinner, Beate [2 ]
von Witzleben, Adrian [1 ]
Lechel, Andre [3 ]
Meyer, Patrick [4 ]
Mayer-Steinacker, Regine [5 ]
von Baer, Alexandra [6 ]
Schultheiss, Markus [6 ]
Wirtz, Christian R. [7 ]
Moeller, Peter [1 ]
Mellert, Kevin [1 ]
机构
[1] Univ Ulm, Inst Pathol, Ulm, Germany
[2] Med Univ Graz, Div Biomed Res, Graz, Austria
[3] Univ Ulm, Dept Internal Med 1, Ulm, Germany
[4] Univ Ulm, Dept Dermatol, Ulm, Germany
[5] Univ Ulm, Dept Internal Med 3, Ulm, Germany
[6] Univ Ulm, Dept Trauma Surg, Ulm, Germany
[7] Univ Ulm, Dept Neurosurg, Ulm, Germany
关键词
POTENTIAL THERAPEUTIC TARGETS; GROWTH-FACTOR RECEPTOR; CELL-LINE; TRANSCRIPTION FACTORS; PROGNOSTIC-FACTORS; LUNG-CANCER; PDGFR-ALPHA; C-MET; GENES; EGFR;
D O I
10.1038/s41598-017-02174-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Chordomas are rare tumours of the bone arising along the spine from clivus to sacrum. We compared three chordoma cell lines of the clivus region including the newly established clivus chordoma cell line, U-CH14, with nine chordoma cell lines originating from sacral primaries by morphology, on genomic and expression levels and with patient samples from our chordoma tissue bank. Clinically, chordomas of the clivus were generally smaller in size at presentation and patients with sacral chordomas had more metastases and more often recurrent disease. All chordoma cell lines had a typical physaliphorous morphology and expressed brachyury, S100-protein and cytokeratin. By expression analyses we detected differentially expressed genes in the clivus derived cell lines as compared to the sacral cell lines. Among these were HOXA7, HOXA9, and HOXA10 known to be important for the development of the anterior-posterior body axis. These results were confirmed by qPCR. Immunohistologically, clivus chordomas had no or very low levels of HOXA10 protein while sacral chordomas showed a strong nuclear positivity in all samples analysed. This differential expression of HOX genes in chordomas of the clivus and sacrum suggests an oncofetal mechanism in gene regulation linked to the anatomic site.
引用
收藏
页数:12
相关论文
共 55 条
[1]  
Abe M, 2006, ONCOL REP, V15, P797
[2]   Immunohistochemical expression of receptor tyrosine kinase PDGFR-α, c-Met, and EGFR in skull base chordoma [J].
Akhavan-Sigari, R. ;
Abili, M. ;
Gaab, M. R. ;
Rohde, V. ;
Zafar, N. ;
Emami, P. ;
Ostertag, H. .
NEUROSURGICAL REVIEW, 2015, 38 (01) :89-98
[3]   Expression of vascular endothelial growth factor receptor 2 (VEGFR-2), inducible nitric oxide synthase (iNOS), and Ki-M1P in skull base chordoma: a series of 145 tumors [J].
Akhavan-Sigari, R. ;
Gaab, M. R. ;
Rohde, V. ;
Brandis, A. ;
Tezval, H. ;
Abili, M. ;
von Eckardstein, K. ;
Ostertag, H. .
NEUROSURGICAL REVIEW, 2014, 37 (01) :79-88
[4]  
Akhavan-Sigari R, 2014, ANTICANCER RES, V34, P623
[5]   HOX expression patterns identify a common signature for favorable AML [J].
Andreeff, M. ;
Ruvolo, V. ;
Gadgil, S. ;
Zeng, C. ;
Coombes, K. ;
Chen, W. ;
Kornblau, S. ;
Baron, A. E. ;
Drabkin, H. A. .
LEUKEMIA, 2008, 22 (11) :2041-2047
[6]   Prognostic Factors in Surgical Resection of Sacral Chordoma [J].
Angelini, Andrea ;
Pala, Elisa ;
Calabro, Teresa ;
Maraldi, Marco ;
Ruggieri, Pietro .
JOURNAL OF SURGICAL ONCOLOGY, 2015, 112 (04) :344-351
[7]   Characterization of cancer stem-like cells in chordoma Laboratory investigation [J].
Aydemir, Esra ;
Bayrak, Omer Faruk ;
Sahin, Fikrettin ;
Atalay, Basar ;
Kose, Gamze Torun ;
Ozen, Mustafa ;
Sevli, Serhat ;
Dalan, Altay Burak ;
Yalvac, Mehmet Emir ;
Dogruluk, Turgut ;
Ture, Ugur .
JOURNAL OF NEUROSURGERY, 2012, 116 (04) :810-820
[8]   Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma [J].
Barth, TFE ;
Martin-Subero, JI ;
Joos, S ;
Menz, CK ;
Hasel, C ;
Mechtersheimer, G ;
Parwaresch, RM ;
Lichter, P ;
Siebert, R ;
Möller, P .
BLOOD, 2003, 101 (09) :3681-3686
[9]  
Bergh P, 2000, CANCER-AM CANCER SOC, V88, P2122, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2122::AID-CNCR19>3.0.CO
[10]  
2-1